Table 2.
Antiviral treatments for respiratory viruses
| Virus | Known and recommended treatment | Potential therapies |
|---|---|---|
| Influenza | Neuraminidase inhibitors (zanamivir or oseltamivir)a Amantadine |
|
| Parainfluenza | Ribavirinb,c IVIGb |
|
| Respiratory syncytial virus | Palivizumab Ribavirinc |
|
| Human metapneumovirus | Ribavirinb,c IVIGb |
|
| Adenovirus | Ribavirinb,c Cidofovirb Brincidofovird |
IVIG, intravenous immunoglobulin.
a
Effective at reducing disease severity and duration.
b
In vitro activity present but no recommendations on treatment are currently available due to lack of data.
c
Can be administered orally, intravenously or in nebulized form.
d
In Phase III clinical trials.